Organon & Co | OGN - Trade Debtors


Organon & Co reported $1.38B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Celltrion KRW 2.01T 39.71B Mar/2026
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 1.23M 1.18M Mar/2026
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
Kangmei Pharma CNY 2.92B 228.09M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Merck USD 11.78B 345M Dec/2025
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Organigram Holdings CAD 53.39M 3.45M Mar/2026
Organon & Co USD 1.38B 53M Mar/2026
Ovoca Bio EUR 39K 408K Jun/2025
Pharma Mar EUR 51.19M 9.4M Mar/2026
Qiagen NV USD 402.61M 9.05M Dec/2025
Sartorius EUR 366.6M 74.9M Mar/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 109.07M 2M Sep/2025
Zealand Pharma A/S 340M 94.1M Dec/2025